Edition:
United Kingdom

Lennox International Inc (LII.N)

LII.N on New York Stock Exchange

216.48USD
19 Jan 2018
Change (% chg)

$2.49 (+1.16%)
Prev Close
$213.99
Open
$214.78
Day's High
$216.79
Day's Low
$214.05
Volume
50,094
Avg. Vol
87,203
52-wk High
$216.79
52-wk Low
$150.47

Select another date:

Wed, Dec 20 2017

BRIEF-Ovid Therapeutics Announces TAK-935/OV935 Granted Orphan Drug Designation By U.S. FDA For Treatment Of Lennox-Gastaut Syndrome

* OVID THERAPEUTICS ANNOUNCES TAK-935/OV935 GRANTED ORPHAN DRUG DESIGNATION BY U.S. FDA FOR TREATMENT OF LENNOX-GASTAUT SYNDROME

BRIEF-Lennox International Sees Fy18 Revenue Up 3 To 7 Percent

* REAFFIRMS FY 2017 ADJUSTED EARNINGS PER SHARE VIEW $7.75 TO $8.05 FROM CONTINUING OPERATIONS

BRIEF-Lennox International says Lpac, co entered into amendment to amended, restated receivables purchase agreement initially dated Nov 18, 2011

* Lennox International - ‍as of Nov 13, Lennox, Lpac, co entered into amendment to amended, restated receivables purchase agreement initially dated nov 18, 2011

Select another date: